Evidence that members of the secretory aspartyl proteinase gene family, in particular SAP2, are virulence factors for Candida vaginitis

Journal of Infectious Diseases

Volumn 179, Issue 1, 1999, Pages 201-208

  De Bernardis, Flavia ^b   Arancia, Silvia ^b   Morelli, Luisella ^b   Hube, Bernhard ^b   Sanglard, Dominique ^b   Schäfer, Wilhelm ^b   Cassone, Antonio ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC PROTEINASE; ESTROGEN; PEPSTATIN; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; ENZYME ACTIVITY; FEMALE; FUNGUS HYPHAE; GENE DISRUPTION; GENE INSERTION; GENE TARGETING; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; RAT; VAGINA CANDIDIASIS; VAGINA DISCHARGE;

ANIMALS; ASPARTIC ENDOPEPTIDASES; BASE SEQUENCE; CANDIDA ALBICANS; CANDIDIASIS; DISEASE MODELS, ANIMAL; DNA PRIMERS; FEMALE; FUNGAL PROTEINS; GENE DELETION; GENES, FUNGAL; MULTIGENE FAMILY; POLYMERASE CHAIN REACTION; RATS; RATS, WISTAR; VAGINITIS; VIRULENCE;

EID: 0004790502     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314546     Document Type: Article

References (41)

1. Odds FC. Candida and candidiasis. 2nd ed. London: Balliere Tindall, 1988.
2. Fisher-Hogh SP, Hutwagner L. Opportunistic candidiasis: an epidemic of the 1980s. Clin Infect Dis 1995;21:897-904.
3. Holmberg K, Meyer RD. Fungal infectious in patients with AIDS and AIDS-related complex. Scand J Infect Dis 1986;18:179-85.
4. Klein RS, Harris CA, Butkus Small C, Moll B, Lesser M, Friendland GH. Oral candidiasis in high risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med 1984;311:354-7.
5. Kiehn TE, Edwards FF, Armstrong D. The prevalence of yeast in clinical specimens from cancer patients. Am J Clin Pathol 1980;73:518-21.
6. Cutler JE. Putative virulence factors of Candida albicans. Annu Rev Microbiol 1991;45:187-218.
7. Ruchel R, De Bernardis F, Ray TL, Sullivan PA, Cole GT. Candida acid proteinases. J Med Vet Mycol 1992;30(suppl 1):123-32.
8. Hube B. Candida albicans secreted aspartyl proteinases. Curr Top Mycol 1996;7:55-69.
9. Ray TL, Payne CD. Candida albicans acid proteinase: a role in virulence. In: Ayoub EM, Cassell WC, Branche Jr, Henry TJ, eds. Microbiol determinants of virulence and host response. Washington, DC: American Society for Microbiology, 1990:163-78.
10. Cassone A, De Bernardis F, Mondello F, Ceddia T, Agatensi L. Evidence for a correlation between proteinase secretion and vulvovaginal candidosis. J Infect Dis 1987;156:777-83.
11. White TC, Agabian N. Candida albicans secreted aspartyl proteinases: isoenzyme pattern is determined by cell type, levels are determined by environmental factors. J Bacteriol 1995;177:5215-21.
12. De Bernardis F, Agatensi L, Rossi IK, et al. Evidence for a role for secreted aspartate proteinase of Candida albicans in vulvovaginal candidiasis. J Infect Dis 1990;161:1276-83.
13. Kwon-Chung KJ, Lehman D, Good C, Magee PT. Genetic evidence for role of extracellular proteinase in virulence of Candida albicans. Infect Immun 1985;49:571-5.
14. Monod M, Togni G, Hube B, Sanglard D. Multiplicity of genes encoding secreted aspartic proteinases in Candida species. Mol Microbiol 1994;13: 357-68.
15. Hube B, Monod M, Shofield DA, Brown AJP, Gow NAR. Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans. Mol Microbiol 1994;14:87-9.
16. Morrow B, Srikantha T, Soll DR. Transcription of the gene for a pepsinogen, PEPI, is regulated by white-opaque switching in Candida albicans. Mol Cell Biol 1992;12:2997-3005.
17. De Bernardis F, Cassone A, Sturtevant J, Calderone R. Expression of Candida albicans SAP1 and SAP2 in experimental vaginitis. Infect Immun 1995; 63:1887-92.
18. White TC, Miyasaki SH, Agabian N. Three distinct secreted aspartyl proteinases in Candida albicans. J Bacteriol 1993;175:6126-33.
19. Wright RJ, Carne A, Hieber AD, Lamont IL, Emerson GW, Sullivan PA. A second gene for a secreted aspartate proteinase in Candida albicans. J Bacteriol 1992;174:7848-53.
20. Rüchel R. Cleavage of immunoglobulins by pathogenic yeasts of the germs Candida. Microbiol Sci 1986;3:316-9.
21. Hattori M, Yoshiura K, Negi M, Ogawa H. Keratinolytic proteinase produced by Candida albicans. J Med Vet Mycol 1984;22:175-83.
22. Rüchel R. A variety of Candida proteinases and their possible targets of proteolytic attack in the host. Zentralbl Bakteriol 1984;257:266-74.
23. Tsushima H, Mine H, Kawakami Y, Hyodoh F, Ueki A. Candida albicans aspartic proteinase cleaves and inactivates human epidermal cysteine proteinase inhibitor, cystatin A. Microbiology 1994;140:167-71.
24. Kaminishi H, Tanaka M, Cho T, Maeda H, Hagihara Y. Activation of the plasma kallikrein-kinin system by Candida albicans proteinase. Infect Immun 1990;58:2139-43.
25. De Bernardis F, Boccanera M, Adriani D, Spreghini E, Sartori G, Cassone A. Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats. Infect Immun 1997;65:3399-405.
26. Borg M, Rüchel R. Demonstration of fungal proteinase during phagocytosis of Candida albicans and Candida tropicalis. J Med Vet Mycol 1990;28: 3-14.
27. Hube B, Sanglard D, Odds FC, et al. Disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2, and SAP3 of Candida albicans attenuates virulence. Infect Immun 1997;65:3529-38.
28. Sanglard D, Hube B, Monod M, Odds FC, Gow NAR. A triple deletion of the secreted aspartyl proteinase genes SAP4, SAP5, and SAP6 of Candida albicans causes attenuated virulence. Infect Immun 1997;65:3539-46.
29. De Bernardis F, Lorenzini R, Verticchio R, Agatensi L, Cassone A. Isolation, acid proteinase secretion, and experimental pathogenicity of Candida parapsilosis from outpatients with vaginitis. J Clin Microbiol 1989;27: 2598-603.
30. De Bernardis F, Chiani P, Ciccozzi M, et al. Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus. Infect Immun 1996;64:466-71.
31. Ross IK, De Bernardis F, Emerson GW, Cassone A, Sullvan PA. The secreted aspartate proteinase of Candida albicans: physiology of secretion and virulence of a proteinase-deficient mutant. J Gen Microbiol 1990;136:687-94.
32. Ibrahim AS, Filler SG, Sanglard D, Edwards JE, Hube B. Secreted aspartyl proteinases and the interaction of Candida albicans with human endothelial cells. Infect Immun 1998;66:3003-5.
33. Angiolella L, Torosantucci A, Carruba G, Cassone A. Nutritional dependent modulation of protein synthesis in Candida albicans during germ tube formation or maintenance of the yeast form in N-acetyl glucosamine media. FEMS Microbiol Lett 1996;36:231-7.
34. Arancia S, Sandini S, Cassone A, De Bernardis F, La Valle R. Construction and use of PCR primers from a 70 Kda heat shock protein gene for identification of Candida albicans. Mol Cell Probes 1997;11:329-36.
35. Sobel J, Hasegawa A, De Bernardis F, et al. Animal models for fungal infections. Med Mycol 1998;36(suppl 1):129-36.
36. De Bernardis F, Adriani D, Lorenzini R, Pontieri E, Carruba G, Cassone A. Filamentous growth and elevated vaginopathic potential of a nongerminative variant of Candida albicans expressing low virulence in systemic infection. Infect Immun 1993;61:1500-8.
37. De Bernardis F, Muhlschlegel FA, Cassone A, Fonzi WA. The pH of the host niche controls gene expression in and virulence of Candida albicans. Infect Immun 1998;66:3317-25.
38. Ghannoum M, Abu Elteen K. Correlative relationship between proteinase production, adherence, and pathogenicity of various strains of Candida albicans. J Med Vet Mycol 1986;24:407-13.
39. Fidel PL, Sobel JD. Immunopathogenesis of recurrent vulvovaginal candidiasis. Clin Microbiol Rev 1996;9:335-48.
40. Fallon K, Bausch K, Noonan J, Huguenel E, Tamburini P. Role of aspartic proteases in disseminated Candida albicans infection in mice. Infect Immun 1997;65:551-6.
41. Cassone A, Boccanera M, Adriani D, Santoni G, De Bernardis F. Rats clearing a vaginal infection by Candida albicans acquire specific antibody-mediated resistance to vaginal reinfection. Infect Immun 1995;63:2619-24.